Kimberly Freeman
Impact in
- Small Animals top 2%
- Animal testing and alternatives
-
- Effects and risks of endocrine disrupting chemicals
- Toxic Organic Pollutants Impact
Papers in
-
- Drug-Induced Hepatotoxicity and Protection 6
- Pharmacogenetics and Drug Metabolism 5
- Oncology 7
- Drug Transport and Resistance Mechanisms 7
- Co-authors
- Stephen Ferguson (5 shared papers)Richard Judson (3 shared papers)Melvin E. Andersen (3 shared papers)Harvey J. Clewell (2 shared papers)John F. Wambaugh (2 shared papers)Kenneth R. Brouwer (9 shared papers)Barbara A. Wetmore (2 shared papers)Mark A. Sochaski (2 shared papers)
- Journals
- Toxicological Sciences (4 papers)Drug Metabolism and Disposition (2 papers)Pharmacogenetics and Genomics (1 paper)Toxicology and Applied Pharmacology (1 paper)Drug Metabolism and Pharmacokinetics (1 paper)
- Partner nations
- United StatesNorwayUkraine
In The Last Decade
Kimberly Freeman
19 papers receiving 745 citations
Peers
Comparison fields: 5 of 85
- Small Animals 153
- Health, Toxicology and Mutagenesis 285
- Pharmacology 156
- Chemical Health and Safety 12
- Computational Theory and Mathematics 143
Countries citing papers authored by Kimberly Freeman
This map shows the geographic impact of Kimberly Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Freeman more than expected).
Fields of papers citing papers by Kimberly Freeman
This network shows the impact of papers produced by Kimberly Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Freeman. The network helps show where Kimberly Freeman may publish in the future.
Co-authors
The 25 scholars most cited alongside Kimberly Freeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 327 | |
| 2 | 2013 | 98 | |
| 3 | 2010 | 47 | |
| 4 | 2017 | 42 | |
| 5 | 2015 | 41 | |
| 6 | 2004 | 30 | |
| 7 | 2016 | 26 | |
| 8 | 2010 | 22 | |
| 9 | 2018 | 19 | |
| 10 | 2013 | 19 | |
| 11 | 2016 | 17 | |
| 12 | 2017 | 17 | |
| 13 | 2015 | 15 | |
| 14 | 2017 | 14 | |
| 15 | Therapeutic focus. Minocycline in the treatment of acne. | 1989 | 9 |
| 16 | 2019 | 8 | |
| 17 | 2008 | 8 | |
| 18 | 2004 | 1 | |
| 19 | 2018 | 1 |
About Kimberly Freeman
Kimberly Freeman is a scholar working on Pharmacology, Oncology, Epidemiology, Hepatology and Molecular Biology, having authored 19 papers that have together received 761 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Drug-Induced Hepatotoxicity and Protection (6 papers), Pharmacogenetics and Drug Metabolism (5 papers), Liver Disease Diagnosis and Treatment (3 papers), Liver physiology and pathology (2 papers), Effects and risks of endocrine disrupting chemicals (2 papers), Muscle metabolism and nutrition (1 paper) and High Altitude and Hypoxia (1 paper). The work is most often cited by research in Small Animals (153 citations), Health, Toxicology and Mutagenesis (285 citations), Pharmacology (156 citations), Chemical Health and Safety (12 citations) and Computational Theory and Mathematics (143 citations). Kimberly Freeman has collaborated with scholars based in United States, Norway and Ukraine. Frequent co-authors include Stephen Ferguson, Richard Judson, Melvin E. Andersen, Harvey J. Clewell, John F. Wambaugh, Kenneth R. Brouwer, Barbara A. Wetmore, Mark A. Sochaski, Russell S. Thomas and Keith A. Houck. Their work appears in journals such as Toxicological Sciences, Drug Metabolism and Disposition, Pharmacogenetics and Genomics, Toxicology and Applied Pharmacology and Drug Metabolism and Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.